RaySearch's Innovations for Particle Therapy at PTCOG 63
RaySearch Laboratories AB (publ) is set to make a significant impact at the upcoming PTCOG 63 conference, scheduled for June 3-6, 2025, in Buenos Aires, Argentina. The company will be presenting its latest advancements in software technology, notably enhancing particle therapy, at booth #08. This is an exciting opportunity for industry professionals to witness firsthand how RaySearch aims to reshape cancer treatment through intelligent solutions.
Leading the Way in Innovative Cancer Care
RaySearch has long been at the forefront of cancer treatment technology, and its innovative products—including RayStation®, RayCare®, RayIntelligence®, and RayCommand®—are designed to facilitate complex cancer care in a more effective manner. These tools enable a seamless integration of various therapy modes, ensuring a comprehensive approach to patient management.
Key Features of Particle Therapy Innovations
The company’s booth at PTCOG 63 will showcase several key innovations in particle therapy:
- - Proton Arc Therapy: This clinical application offers improved dose conformity and safeguards surrounding organs during treatment, maximizing the effectiveness of cancer therapy with minimized side effects.
- - Monte Carlo Dose Engine: Utilizing ultra-fast GPU computation, this engine ensures high accuracy in dose calculation and optimization, vital for effective treatment planning.
- - Robust Optimization: This feature manages uncertainties comprehensively, enabling rigorous evaluation of treatment plans, ensuring that patients receive the most tailored therapy possible.
- - Upright Treatment Planning: This acknowledges the essential aspect of patient comfort and optimizes facility layout by supporting fixed beamline treatments.
Beyond these highlights, visitors can expect live demonstrations of additional advanced functionalities from the RaySearch product suite. The overarching goal is to reaffirm the company's commitment to advancing the realm of radiotherapy, making it not only smarter and safer but also more efficient.
Advanced Innovations Showcased
At this year's event, RaySearch plans to exhibit high-speed adaptive replanning capabilities in RayStation, alongside advancements in AI-driven image segmentation. Both sophisticated machine learning technology and traditional automated planning algorithms will be used to enhance automated treatment planning. Also featured are three new deep learning planning models unique to RayStation, alongside an integrated version of ECHO—an advanced planning algorithm developed by Memorial Sloan Kettering Cancer Center in the USA.
Another significant addition is the upgraded Plan Explorer module, which provides a centralized platform for exploring and comparing treatment options across multiple modalities and planning strategies. This innovative tool is designed to streamline the planning process and facilitate informed clinical decisions.
RayCare's role in oncology will also be highlighted, showcasing its capabilities in orchestrating workflows across oncology treatment processes. This includes features that automate high-level tasks and ensure seamless integration with RayStation, leading to an enhanced standard of care that prioritizes patient-centered approaches.
Harnessing Data for Better Treatment
RayIntelligence, RaySearch's cloud-based oncology analytics system, will illustrate how data can be effectively harnessed to provide actionable insights that support personalized cancer treatment strategies. By aggregating fragmented clinical data, it allows for a cohesive overview of treatment plans, clinic operations, and system performance, thereby fostering improved decision-making.
Additionally, RayCommand will be demonstrated as the essential bridge connecting treatment machines with planning and information systems, ensuring precise coordination of all operational components involved in patient care.
Invitation to Experience the Future of Particle Therapy
RaySearch invites industry professionals, healthcare providers, and stakeholders to visit booth #08 at PTCOG 63. Attendees will have the chance to engage with these groundbreaking technologies and discover how RaySearch is influencing the future of particle therapy. By continually striving for innovation, RaySearch is dedicated to providing healthcare professionals with the tools necessary to enhance cancer patient care worldwide.
For more information about RaySearch and its pioneering contributions to medical technology, visit their official website at
raysearchlabs.com.
RaySearch Laboratories AB was founded in 2000 and has successfully sold its software solutions to over 1,100 clinics across 47 countries, demonstrating its commitment to improving cancer care globally.